VAERS Explorer
Back to explore

Report #2856070

Received Aug 29, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (2)

Influenza like illnessMalaise

Symptom narrative

very sick; Flu type reaction; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced sickness (Verbatim: very sick) and influenza-like symptoms (Verbatim: Flu type reaction). The outcome of the sickness and influenza-like symptoms were not reported. It was unknown if the reporter considered the sickness and influenza-like symptoms to be related to Shingrix. It was unknown if the company considered the sickness and influenza-like symptoms to be related to Shingrix. Additional Information: GSK receipt date: 05-AUG-2025 The patient had a 3-day flu like reaction and was very much sick. The patient won't take the second dose.